113 related articles for article (PubMed ID: 1971971)
1. Rejection of transgenic skin expressing a xeno-class I antigen is CD4-dependent and CD8-independent.
Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
Transplant Proc; 1990 Jun; 22(3):1059-60. PubMed ID: 1971971
[No Abstract] [Full Text] [Related]
2. Xenograft rejection of class I-expressing transgenic skin is CD4-dependent and CD8-independent.
Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
Transplant Proc; 1990 Oct; 22(5):2335-6. PubMed ID: 2120817
[TBL] [Abstract][Full Text] [Related]
3. Human CD4+ T cells mediate rejection of porcine xenografts.
Friedman T; Shimizu A; Smith RN; Colvin RB; Seebach JD; Sachs DH; Iacomini J
J Immunol; 1999 May; 162(9):5256-62. PubMed ID: 10228000
[TBL] [Abstract][Full Text] [Related]
4. Rejection of human xenoskins by non-CD4 T-cell populations in mice.
Uchida T; Tomita Y; Zheng QW; Kishihara K; Nomoto K; Yasui H
Transplant Proc; 1996 Apr; 28(2):662. PubMed ID: 8623332
[No Abstract] [Full Text] [Related]
5. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
6. CD4+ lymphocytes play a dominant role in murine xenograft rejection.
Pierson RN; Winn HJ; Russell PS; Auchincloss H
Transplant Proc; 1989 Feb; 21(1 Pt 1):519. PubMed ID: 2565056
[No Abstract] [Full Text] [Related]
7. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
Wecker H; Grusby MJ; Auchincloss H
Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
[No Abstract] [Full Text] [Related]
8. Allograft rejection in athymic nude rats by transferred T cell subsets. II. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to an isolated MHC class I disparity.
Bell EB; Rejali D; Whitby EH; Sparshott SM; Yang CP
Transplantation; 1990 Oct; 50(4):690-6. PubMed ID: 1977220
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
Koulmanda M; Laufer TM; Auchincloss H; Smith RN
Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
[TBL] [Abstract][Full Text] [Related]
10. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection.
Krieger NR; Fathman CG
J Heart Lung Transplant; 1997 Mar; 16(3):263-7. PubMed ID: 9087868
[No Abstract] [Full Text] [Related]
11. Alloreactive T cells that do not require TCR and CD8 coengagement are present in naive mice and contribute to graft rejection.
Smith PA; Potter TA
J Immunol; 1998 Jun; 160(11):5382-9. PubMed ID: 9605138
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.
Ward PL; Koeppen HK; Hurteau T; Rowley DA; Schreiber H
Cancer Res; 1990 Jul; 50(13):3851-8. PubMed ID: 2112981
[TBL] [Abstract][Full Text] [Related]
13. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.
Youssef AR; Otley C; Mathieson PW; Smith RM
Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743
[TBL] [Abstract][Full Text] [Related]
14. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
Tanaka K; Sonoda K; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
16. Generation of H-2 class II-reactive CD8+ cells in mice after class II-disparate skin graft rejection.
Kawai K; Kobayashi E; Matsumoto Y; Fujiwara M
Transplantation; 1992 Jan; 53(1):237-9. PubMed ID: 1346347
[No Abstract] [Full Text] [Related]
17. Evidence that a "four-cell cluster" may prime cytotoxic T-cells during graft rejection.
Lee R; Glimcher LH; Auchincloss H
Transplant Proc; 1993 Feb; 25(1 Pt 2):847-9. PubMed ID: 8442245
[No Abstract] [Full Text] [Related]
18. Effect of FK 506 on CD4+ and CD8+ T-cell function in vivo.
Fukuzawa M; Okada A; Shearer GM
Transplant Proc; 1991 Dec; 23(6):2945-7. PubMed ID: 1721321
[No Abstract] [Full Text] [Related]
19. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
20. In vivo immunosuppressive effects of monoclonal antibodies specific for CD3+, CD4+, CD8+, and MHC class II positive cells.
Stevens HP; Roche N; Hovius SE; Jonker M
Transplant Proc; 1990 Aug; 22(4):1783-4. PubMed ID: 2143861
[No Abstract] [Full Text] [Related]
[Next] [New Search]